Literature DB >> 29101263

Assessment of liver fibrosis with the gamma-glutamyl transpeptidase to platelet ratio: a multicentre validation in patients with HBV infection.

Xiao-Jie Lu1,2, Xiu-Hui Li3, Zhao-Xin Yuan4,5, Hai-Ying Sun5, Xiao-Chen Wang1,2, Xiaolong Qi6, Xin Zhang7, Beicheng Sun1,2.   

Abstract

Entities:  

Keywords:  chronic hepatitis B; diagnostic performance; gamma-glutamyl transpeptidase to platelet ratio; liver fibrosis; non-invasive assessment

Mesh：

Substances：

Year:  2017        PMID： 29101263     DOI： 10.1136/gutjnl-2017-315299

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

1.  FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients.

Authors:  Xiao-Jie Lu; Xiao-Jun Yang; Jing-Yu Sun; Xin Zhang; Zhao-Xin Yuan; Xiu-Hui Li
Journal:  Biomark Res       Date:  2020-09-25

2.  The Delta-4 fibrosis score (D4FS): A novel fibrosis score in chronic hepatitis D.

Authors:  Ben L Da; Pallavi Surana; David E Kleiner; Theo Heller; Christopher Koh
Journal:  Antiviral Res       Date:  2019-12-16       Impact factor: 5.970

Review 3.  Transient Elastography for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis.

Authors:  Xiaolong Qi; Min An; Tongwei Wu; Deke Jiang; Mengyun Peng; Weidong Wang; Jing Wang; Chunqing Zhang; On Behalf Of The Chess Study Group
Journal:  Can J Gastroenterol Hepatol       Date:  2018-05-24

4.  A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels.

Authors:  Yanping Chen; Yanping Li; Na Li; Xiude Fan; Chunyan Li; Pingping Zhang; Qunying Han; Zhengwen Liu
Journal:  Dis Markers       Date:  2018-10-14       Impact factor: 3.434

5.  A simple algorithm for non-invasive diagnosis of significant liver histological changes in patients with CHB and normal or mildly elevated alanine transaminase levels.

Authors:  Qiang Li; Chenlu Huang; Wei Xu; Qiankun Hu; Liang Chen
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

6.  Lnc-TCL6 is a potential biomarker for early diagnosis and grade in liver-cirrhosis patients.

Authors:  Lei-Jia Li; Xiao-Ying Wu; Si-Wei Tan; Zi-Jun Xie; Xue-Mei Pan; Shun-Wen Pan; Wu-Ri-Na Bai; Hai-Jiao Li; Hui-Ling Liu; Jie Jiang; Bin Wu
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-10-11

7.  Radiomics analysis of contrast-enhanced CT for staging liver fibrosis: an update for image biomarker.

Authors:  Jincheng Wang; Shengnan Tang; Yingfan Mao; Jin Wu; Shanshan Xu; Qi Yue; Jun Chen; Jian He; Yin Yin
Journal:  Hepatol Int       Date:  2022-03-28       Impact factor: 9.029

8.  Optimized cutoffs of gamma-glutamyl transpeptidase-to-platelet ratio, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 scoring systems for exclusion of cirrhosis in patients with chronic hepatitis B.

Authors:  Xiaoqing Liu; Hu Li; Li Wei; Qiao Tang; Peng Hu
Journal:  Hepatol Commun       Date:  2022-03-21

9.  A Novel Prediction Model for Significant Liver Fibrosis in Patients with Chronic Hepatitis B.

Authors:  Yaqiong Chen; Jiao Gong; Wenying Zhou; Yusheng Jie; Zhaoxia Li; Yutian Chong; Bo Hu
Journal:  Biomed Res Int       Date:  2020-07-08       Impact factor: 3.411

Review 10.  Review of Serum Biomarkers and Models Derived from Them in HBV-Related Liver Diseases.

Authors:  JianPing Wu; WeiLin Mao
Journal:  Dis Markers       Date:  2020-07-21       Impact factor: 3.434
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.